These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26508600)

  • 1. Venture Capital Investment in the Life Sciences in Switzerland.
    Hosang M
    Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venture Capital Investments for Life Sciences Start-ups in Switzerland.
    Gantenbein P; Herold N
    Chimia (Aarau); 2014 Dec; 68(12):836-9. PubMed ID: 26508597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
    Fleming JJ
    Health Aff (Millwood); 2015 Feb; 34(2):271-6. PubMed ID: 25646107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflexive expectations in innovation financing: An analysis of venture capital as a mode of valuation.
    Birch K
    Soc Stud Sci; 2023 Feb; 53(1):29-48. PubMed ID: 35971623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The winding journey of biotech capital raising: deciphering the jargon.
    Frame N; Casasanta M; Ben-Joseph O
    Trends Biotechnol; 2023 Oct; 41(10):1213-1215. PubMed ID: 37451947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other ways of financing your company.
    Aldag J; Kessel M; Ibrahim A; Hill R; McCubbin P
    Nat Biotechnol; 2008 Feb; 26(2):155-7. PubMed ID: 18273945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A venture capital view of challenges, opportunities, and innovation in biomedical research.
    Ratcliffe LT
    Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fueling innovation in medical devices (and beyond): venture capital in health care.
    Ackerly DC; Valverde AM; Diener LW; Dossary KL; Schulman KA
    Health Aff (Millwood); 2009; 28(1):w68-75. PubMed ID: 19049999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fostering a new dialogue to improve access to finance for European biopharma SMEs.
    Chantelot E; Suojanen C
    N Biotechnol; 2010 Dec; 27(6):719-23. PubMed ID: 20678597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market entry and exit by biotech and device companies funded by venture capital.
    Burns LR; Housman MG; Robinson CA
    Health Aff (Millwood); 2009; 28(1):w76-86. PubMed ID: 19049998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sticking to the knitting: CIHR, innovation and Canadian biotech.
    Edelson J
    Healthc Q; 2005; 8(3):65-8. PubMed ID: 16078405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venture capital on a shoestring: Bioventures' pioneering life sciences fund in South Africa.
    Masum H; Singer PA
    BMC Int Health Hum Rights; 2010 Dec; 10 Suppl 1(Suppl 1):S8. PubMed ID: 21144079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rise of venture capital and biotechnology in the US and Europe.
    Lee DP; Dibner MD
    Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech venture capital--it's not too late to be early.
    Klausner A
    Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
    [No Abstract]   [Full Text] [Related]  

  • 16. Practice financing strategies should match investors' objectives.
    Messinger SF; Stevenson PB
    Healthc Financ Manage; 1999 May; 53(5):72-6. PubMed ID: 10557994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eli Lilly enters venture capital arena.
    Fletcher L
    Nat Biotechnol; 2001 Nov; 19(11):997-8. PubMed ID: 11689830
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology venture capital booms in Japan.
    Saegusa A
    Nat Biotechnol; 2000 Mar; 18(3):256. PubMed ID: 10700128
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in Venture Capital Investments in Ophthalmology Companies (2011-2021).
    Gupta S; Uppal N; Chang EK; Fetter T; Hunter DG
    Ophthalmology; 2022 Mar; 129(3):353-354. PubMed ID: 34626696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.